We are live on ! Find out more
TM

Triatomic Management Portfolio holdings

AUM $3.39M
1-Year Est. Return 3.35%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
-3.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$149M
AUM Growth
+$29.8M
Cap. Flow
+$22.3M
Cap. Flow %
14.99%
Top 10 Hldgs %
74.78%
Holding
72
New
22
Increased
7
Reduced
12
Closed
17

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$1.33M
2
DDOG icon
Datadog
DDOG
+$1.12M
3
GH icon
Guardant Health
GH
+$1M
4
LYFT icon
Lyft
LYFT
+$914K
5
TOST icon
Toast
TOST
+$803K

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$1.75M
2
PODD icon
Insulet
PODD
+$870K
3
AGNT
AGNT Inc
AGNT
+$667K
4
GOTU icon
Gaotu Techedu
GOTU
+$554K
5
ZLAB icon
Zai Lab
ZLAB
+$544K

Sector Composition

Rank Sector Weight
1 Healthcare 7.39%
2 Technology 5.52%
3 Consumer Discretionary 2.99%
4 Energy 1.32%
5 Industrials 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.5T
$864K 0.58%
+4,075
New +$694K
MNDY icon
27
monday.com
MNDY
$3.76B
$857K 0.58%
6,000
NVDA icon
28
NVIDIA
NVDA
$5.01T
$833K 0.56%
30,000
GH icon
29
Guardant Health
GH
$21.3B
$822K 0.55%
+35,072
New +$1M
AGNT
30
AGNT Inc
AGNT
$674M
$801K 0.54%
63,101
-50,000
-44% -$667K
TOST icon
31
Toast
TOST
$19B
$723K 0.49%
+40,735
New +$803K
BNTX icon
32
BioNTech
BNTX
$23.3B
$702K 0.47%
5,636
LYFT icon
33
Lyft
LYFT
$6.22B
$701K 0.47%
+75,674
New +$914K
ADPT icon
34
Adaptive Biotechnologies
ADPT
$3.68B
$676K 0.45%
76,560
-54,245
-41% -$478K
MRNA icon
35
Moderna
MRNA
$22B
$676K 0.45%
4,400
-1,000
-19% -$165K
AEHR icon
36
Aehr Test Systems
AEHR
$2.99B
$648K 0.44%
20,885
-3,615
-15% -$116K
DMTK
37
DELISTED
DermTech, Inc. Common Stock
DMTK
$569K 0.38%
154,652
+27,444
+22% +$116K
TOI icon
38
The Oncology Institute
TOI
$513M
$549K 0.37%
810,145
+292,666
+57% +$373K
BILL icon
39
BILL Holdings
BILL
$4.7B
$527K 0.35%
+6,500
New +$603K
BEKE icon
40
KE Holdings
BEKE
$19.1B
$500K 0.34%
+26,523
New +$491K
AMD icon
41
Advanced Micro Devices
AMD
$790B
$416K 0.28%
4,245
-1,755
-29% -$143K
NTLA icon
42
Intellia Therapeutics
NTLA
$1.5B
$373K 0.25%
10,000
-10,000
-50% -$392K
ADPT icon
43
CALL
Adaptive Biotechnologies
ADPT
$3.68B
$353K 0.24%
40,000
-40,000
-50% -$353K
RIVN icon
44
Rivian
RIVN
$22.2B
$294K 0.2%
19,000
SNTI icon
45
Senti Biosciences Holdings
SNTI
$11.5M
$249K 0.17%
21,088
+5,920
+39% +$92.1K
TSM icon
46
TSMC
TSM
$2.11T
$233K 0.16%
+2,500
New +$224K
RBLX icon
47
Roblox
RBLX
$26.2B
$225K 0.15%
+5,000
New +$191K
OMIC
48
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$202K 0.14%
5,574
+394
+8% +$24.1K
ME
49
DELISTED
23andMe Holding Co
ME
$132K 0.09%
2,891
UNH icon
50
UnitedHealth
UNH
$377B
$99.2K 0.07%
+210
New +$101K

Similar funds

Triatomic Management's Q1 2023 Portfolio in Review

As of Q1 2023, Triatomic Management held 72 positions worth $149M, up 25% from $119M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Triatomic Management deployed $22.3M of net new capital in Q1 2023, opening 22 new positions and adding to 7 existing holdings. Its largest new stake was Pinduoduo: 14,675 shares worth $1.11M.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Samsara, an estimated $1.75M trimmed.

  • Triatomic Management's largest Q1 2023 buy was Pinduoduo: 14,675 shares worth $1.11M.
  • Triatomic Management added most to CareMax, Inc. Class A Common Stock in Q1 2023, an estimated $664K increase.
  • Triatomic Management's biggest Q1 2023 reduction was Samsara, cutting an estimated $1.75M.
  • Triatomic Management fully exited Gaotu Techedu in Q1 2023, selling an estimated $554K.
  • Triatomic Management's ten largest holdings make up 75% of its $149M portfolio in Q1 2023.
  • Triatomic Management opened 22 new positions and closed 17 in Q1 2023.
  • Triatomic Management's portfolio value rose 25% quarter-over-quarter to $149M.

Based on Triatomic Management's 13F filing for Q1 2023, filed 3 May 2023.